264 results on '"Bani, M R"'
Search Results
152. Chronic exercise enhances in vivo and in vitro cytotoxic mechanisms of natural immunity in mice.
- Author
-
MACNEIL, B. and HOFFMAN-GOETZ, L.
- Published
- 1993
- Full Text
- View/download PDF
153. Retroviral vectors.
- Author
-
Vile, Richard, Tuszynski, Anna, and Castleden, Simon
- Abstract
The majority of clinical trials for gene therapy currently employ retroviral-mediated gene delivery. This is because the life cycle of the retrovirus is well understood and can be effectively manipulated to generate vectors that can be efficiently and safely packaged. Here, we review the molecular technology behind the generation of recombinant retroviral vectors. We also highlight the problems associated with the use of these viruses as gene therapy vehicles and discuss future developments that will be necessary to maintain retroviral vectors at the forefront of gene transfer technology. [ABSTRACT FROM AUTHOR]
- Published
- 1996
- Full Text
- View/download PDF
154. Heterogeneity of cytokine production by human malignant melanoma cells.
- Author
-
Armstrong, Cheryl A., Tara, David C., Hart, Charles E., Köck, Andreas, Luger, Thomas A., and Ansel, John C.
- Subjects
MELANOMA ,CYTOKINES ,CELL lines ,TUMORS ,IMMUNE response ,CELL culture - Abstract
Recent investigations indicate that malignant melanoma cells can produce distinct cytokines While differences in the production of single cytokines have been observed among different melanoma cell lines, the extent of variability in the production of single and multiple cytokines between individual melanoma cell lines has not been as thoroughly investigated. A heterogeneity in melanoma cell cytokine production could have important implications for the biology of this aggressive neoplasm since certain cytokines may act as autocrine growth factors or be potent modulators of host immune response to the developing tumor. The purpose of this study is to assess the cytokine production profile of two widely available human melanoma cell lines, A375 and G361. The A375 cell line constitutively expressed the mRNA for IL-1&alfa;, IL-1β and PDGF-A, with increased expression of these cytokines after induction with PMA, GM-CSF mRNA was expressed by the A375 melanoma line only after induction with PMA. No IL-6 mRNA was detected in the A375 melanoma cell line. The cell culture supernatants from the A375 cells likewise contained a parallel increase in IL-1 activity as determined in the D10 bioassay and secreted GM-CSF and PDGF-AA as measured by ELISA. In contrast, the G361 cell line did not express IL-1, GM-CSF or PDGF-A mRNA (constitutively or after PMA induction) but expressed only IL-6 mRNA and secreted IL-6 activity after PMA induction. These results demonstrate a significant heterogeneity in the production of IL-1&alfa; IL-1β IL-6 GM-CSF, and PDGF in two distinct melanoma cell lines. This study demonstrates that individual melanoma cell lines express and secrete multiple cytokines both constitutively and after stimulation with PMA. The immunomodulating and mitogenic properties of these melanoma-derived cytokines may have implications in determining the biologic behavior of different malignant melanomas. [ABSTRACT FROM AUTHOR]
- Published
- 1992
- Full Text
- View/download PDF
155. The Structure and Function of Proteins Involved in Mammalian Pre-mRNA Splicing.
- Author
-
Kramer, A
- Published
- 1996
- Full Text
- View/download PDF
156. Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer.
- Author
-
Davey, Matthew G., Hynes, Sean O., Kerin, Michael J., Miller, Nicola, and Lowery, Aoife J.
- Subjects
BREAST cancer prognosis ,IMMUNOHISTOCHEMISTRY ,EPIDERMAL growth factor ,INDIVIDUALIZED medicine ,GENE expression ,ESTROGEN receptors ,CELL proliferation ,TUMOR markers ,PROGESTERONE receptors - Abstract
Simple Summary: In breast cancer development, the expression of Ki-67 is strongly associated with cancer proliferation and is a known indicator of prognosis and outcome. Ki-67 expression levels are also useful to inform treatment decision making in some cases. As a result, routine measurement of Ki-67 is now widely performed during pathological tumour evaluation. However, the Ki-67 appraisal is not without its limitations and shortcomings—the aim of this study was to provide an overview of Ki-67 use in the clinical setting, the current challenges associated with its measurement, and the novel strategies that will hopefully enhance Ki-67 proliferation indices for prospective breast cancer patients. The advent of molecular medicine has transformed breast cancer management. Breast cancer is now recognised as a heterogenous disease with varied morphology, molecular features, tumour behaviour, and response to therapeutic strategies. These parameters are underpinned by a combination of genomic and immunohistochemical tumour factors, with estrogen receptor (ER) status, progesterone receptor (PgR) status, human epidermal growth factor receptor-2 (HER2) status, Ki-67 proliferation indices, and multigene panels all playing a contributive role in the substratification, prognostication and personalization of treatment modalities for each case. The expression of Ki-67 is strongly linked to tumour cell proliferation and growth and is routinely evaluated as a proliferation marker. This review will discuss the clinical utility, current pitfalls, and promising strategies to augment Ki-67 proliferation indices in future breast oncology. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
157. Serum and Tissue Level of TLR9 in EBV-Associated Oropharyngeal Cancer.
- Author
-
Stępień, Ewa, Strycharz-Dudziak, Małgorzata, Malm, Maria, Drop, Bartłomiej, and Polz-Dacewicz, Małgorzata
- Subjects
CYTOKINES ,OROPHARYNGEAL cancer ,MANN Whitney U Test ,CELL receptors ,TISSUES ,DESCRIPTIVE statistics ,CHI-squared test ,DATA analysis software ,EPSTEIN-Barr virus diseases ,TOLL-like receptors ,BLOOD - Abstract
Simple Summary: The Epstein–Barr virus (EBV) is associated with the development and progression of various epithelial malignancies including cancer in the head and neck region. Toll-like receptors (TLRs) are molecules distinguishing self and non-self antigens. They are required for congenital immune response to infections with viruses such as EBV because, during viral infection, the congenital immunity is the first line of human defense preventing the replication of the virus. Moreover, TLR response may influence the transformation to malignancy. The aim of our study was to assess TLR9 level in patients with diagnosed oropharyngeal cancer with or without EBV infection. We wanted to know whether infection with EBV influences TLR9 level and maybe changes the immune response which may lead to malignant transformation. The results obtained in our research may improve understanding of the role viral infections play in head and neck cancers and influence future diagnosis, prevention and treatment strategies in these malignancies. The Epstein–Barr virus (EBV) is associated with the development of various epithelial malignancies including cancer in the head and neck region. Several studies have shown that Toll-like receptors (TLRs) are required for an innate immune response to infection with human DNA viruses, e.g., EBV. During viral infections, TLR response may influence the transformation to malignancy. The aim of the study was to assess TLR9 serum and tissue level in EBV(+) and EBV(−) oropharyngeal cancer patients. The study involved 78 patients: 42 EBV(+) and 36 EBV(−). EBV DNA was detected in fresh frozen tumor tissue. TLR9 level was measured in homogenate of tumor tissue and in serum. Moreover, in serum samples IL-10, VEGF, TGFβ, TNFα and antibodies against EBV were detected using ELISA test. TLR9 level was significantly lower in EBV(+) patients, both in tissue and serum, while EBVCA, EBNA and VEGF level was statistically higher in EBV(+) patients. An increase in EBVCA and EBNA antibodies titer was correlated with a TLR9 level decrease. TLR9 level was higher in poorly-differentiated tumors (G3), in tumor of larger dimensions (T3-T4) and with lymph nodes involvement (N3-N4) but without statistical significance. High levels of anti-EA antibodies in the majority of EBV(+) patients may point to the reactivation of EBV infection. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
158. Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions.
- Author
-
Hossain, Fokhrul, Majumder, Samarpan, David, Justin, and Miele, Lucio
- Subjects
BREAST tumor treatment ,INDIVIDUALIZED medicine ,METASTASIS ,CANCER relapse ,BREAST tumors - Abstract
Simple Summary: The implementation of precision medicine will revolutionize cancer treatment paradigms. Notably, this goal is not far from reality: genetically similar cancers can be treated similarly. The heterogeneous nature of triple-negative breast cancer (TNBC) made it a suitable candidate to practice precision medicine. Using TNBC molecular subtyping and genomic profiling, a precision medicine-based clinical trial is ongoing. This review summarizes the current landscape and future directions of precision medicine and TNBC. Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous subtype of breast cancer associated with a high recurrence and metastasis rate that affects African-American women disproportionately. The recent approval of targeted therapies for small subgroups of TNBC patients by the US 'Food and Drug Administration' is a promising development. The advancement of next-generation sequencing, particularly somatic exome panels, has raised hopes for more individualized treatment plans. However, the use of precision medicine for TNBC is a work in progress. This review will discuss the potential benefits and challenges of precision medicine for TNBC. A recent clinical trial designed to target TNBC patients based on their subtype-specific classification shows promise. Yet, tumor heterogeneity and sub-clonal evolution in primary and metastatic TNBC remain a challenge for oncologists to design adaptive precision medicine-based treatment plans. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
159. Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
- Author
-
Belhabib, Ismahane, Zaghdoudi, Sonia, Lac, Claire, Bousquet, Corinne, and Jean, Christine
- Subjects
TUMOR diagnosis ,TUMOR treatment ,DISEASE progression ,SURVIVAL ,FIBROBLASTS ,CELL physiology ,CANCER ,PATHOLOGIC neovascularization ,EXTRACELLULAR space ,TUMORS ,DRUG resistance in cancer cells - Abstract
Simple Summary: Stroma modifications observed in solid cancer are now recognized as critical events for cancer progression and as potential therapeutic or diagnostic targets. The recent appreciation of multiple but complex roles of the extracellular matrix (ECM) in cancer, and of the cancer-associated fibroblast (CAF) diversity, has revolutionized the field and raised innovative but challenging questions. In this review, we summarize the latest knowledge regarding the role of the ECM in cancer progression, discuss the potential use of such stromal pro-tumoral modifications as therapeutic or diagnostic targets, and, finally, discuss benefits, disappointments, or even failures, of recently reported stroma-targeting strategies. Solid cancer progression is dictated by neoplastic cell features and pro-tumoral crosstalks with their microenvironment. Stroma modifications, such as fibroblast activation into cancer-associated fibroblasts (CAFs) and extracellular matrix (ECM) remodeling, are now recognized as critical events for cancer progression and as potential therapeutic or diagnostic targets. The recent appreciation of the key, complex and multiple roles of the ECM in cancer and of the CAF diversity, has revolutionized the field and raised innovative but challenging questions. Here, we rapidly present CAF heterogeneity in link with their specific ECM remodeling features observed in cancer, before developing each of the impacts of such ECM modifications on tumor progression (survival, angiogenesis, pre-metastatic niche, chemoresistance, etc.), and on patient prognosis. Finally, based on preclinical studies and recent results obtained from clinical trials, we highlight key mechanisms or proteins that are, or may be, used as potential therapeutic or diagnostic targets, and we report and discuss benefits, disappointments, or even failures, of recently reported stroma-targeting strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
160. Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.
- Author
-
Ahn, Hee-Sung, Ho, Jung Yoon, Yu, Jiyoung, Yeom, Jeonghun, Lee, Sanha, Hur, Soo Young, Jung, Yuyeon, Kim, Kyunggon, Choi, Youn Jin, Dhanasekaran, Danny N., Aoki, Daisuke A., Tsang, Benjamin, and Song, Yong Sang
- Subjects
OVARIAN tumors ,BLOOD proteins ,BRCA genes ,LIQUID chromatography ,PROTEOMICS ,MASS spectrometry ,ENZYME-linked immunosorbent assay ,TUMOR markers ,BODY fluid examination ,DISEASE risk factors - Abstract
Simple Summary: Most hereditary ovarian cancer is associated with BRCA1/2 variants, and risk-reducing salpingo-oophorectomy during the follow-up monitoring of ovarian cancer development in heathy women with the BRCA1/2 variant reduces ovarian cancer incidence. The aim of this study was to identify plasma protein biomarkers that can indicate an increased risk of developing ovarian cancer using a proteomic approach based on a population of genetic variants. Two identified biomarkers among differentially expressed proteins, SPARC and THBS1, had lower plasma concentrations in healthy BRCA1/2 variant carriers than in ovarian cancer patients with the BRCA1/2 variant; concentration of two proteins increased at the onset of ovarian cancer. These protein markers from non-invasive liquid biopsy sampling could be used to help women with the BRCA1/2 variant determine whether to undergo an oophorectomy that could potentially affect the quality of life. Ovarian cancer (OC) is the most lethal gynecologic malignancy and in-time diagnosis is limited because of the absence of effective biomarkers. Germline BRCA1/2 genetic alterations are risk factors for hereditary OC; risk-reducing salpingo-oophorectomy (RRSO) is pursued for disease prevention. However, not all healthy carriers develop the disease. Therefore, identifying predictive markers in the BRCA1/2 carrier population could help improve the identification of candidates for preventive RRSO. In this study, plasma samples from 20 OC patients (10 patients with BRCA1/2 wild type (
wt ) and 10 with the BRCA1/2 variant (var )) and 20 normal subjects (10 subjects with BRCA1/2wt and 10 with BRCA1/2var ) were analyzed for potential biomarkers of hereditary OC. We applied a bottom-up proteomics approach, using nano-flow LC-MS to analyze depleted plasma proteome quantitatively, and potential plasma protein markers specific to the BRCA1/2 variant were identified from a comparative statistical analysis of the four groups. We obtained 1505 protein candidates from the 40 subjects, and SPARC and THBS1 were verified by enzyme-linked immunosorbent assay. Plasma SPARC and THBS1 concentrations in healthy BRCA1/2 carriers were found to be lower than in OC patients with BRCA1/2var . If plasma SPARC concentrations increase over 337.35 ng/mL or plasma THBS1 concentrations increase over 65.28 μg/mL in a healthy BRCA1/2 carrier, oophorectomy may be suggested. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
161. The Blockade of Tumoral IL1β-Mediated Signaling in Normal Colonic Fibroblasts Sensitizes Tumor Cells to Chemotherapy and Prevents Inflammatory CAF Activation.
- Author
-
Díaz-Maroto, Natalia Guillén, Garcia-Vicién, Gemma, Polcaro, Giovanna, Bañuls, María, Albert, Nerea, Villanueva, Alberto, Molleví, David G., and Stolfi, Carmine
- Subjects
DRUG tolerance ,CANCER chemotherapy ,ANTINEOPLASTIC agents ,CANCER cells ,FIBROBLASTS - Abstract
Heterotypic interactions between newly transformed cells and normal surrounding cells define tumor's fate in incipient carcinomas. Once homeostasis has been lost, normal resident fibroblasts become carcinoma-associated fibroblasts, conferring protumorogenic properties on these normal cells. Here we describe the IL1β-mediated interplay between cancer cells and normal colonic myofibroblasts (NCFs), which bestows differential sensitivity to cytotoxic drugs on tumor cells. We used NCFs, their conditioned media (CM), and cocultures with tumor cells to characterize the IL1β-mediated crosstalk between both cell types. We silenced IL1β in tumor cells to demonstrate that such cells do not exert an influence on NCFs inflammatory phenotype. Our results shows that IL1β is overexpressed in cocultured tumor cells. IL1β enables paracrine signaling in myofibroblasts, converting them into inflammatory-CAFs (iCAF). IL1β-stimulated-NCF-CM induces migration and differential sensitivity to oxaliplatin in colorectal tumor cells. Such chemoprotective effect has not been evidenced for TGFβ1-driven NCFs. IL1β induces the loss of a myofibroblastic phenotype in NCFs and acquisition of iCAF traits. In conclusion, IL1β-secreted by cancer cells modify surrounding normal fibroblasts to confer protumorogenic features on them, particularly tolerance to cytotoxic drugs. The use of IL1β-blocking agents might help to avoid the iCAF traits acquisition and consequently to counteract the protumorogenic actions these cells. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
162. Effect of MC1R variant allele status on MSH-ligand induction of dopachrome tautomerase in melanocytes co-cultured with keratinocytes.
- Author
-
Ainger, Stephen A., Wong, Shu S., Roberts, Donald W., Leonard, J. Helen, and Sturm, Richard A.
- Subjects
MELANOMA ,KERATINOCYTES ,GENE frequency ,LIGANDS (Biochemistry) ,PIGMENTATION disorders - Abstract
A co-culture system of melanocytic cells and keratinocytes was used to examine dendricity and dopachrome tautomerase (DCT) responses in low penetrant 'r' homozygote and 'R / +' heterozygote MC1R variant allele expressing cells compared to that of wild-type (WT) cells. The V60L
-/- homozygote r variant cells showed similar responses to ligand as WT MC1R strains, while V92M-/- homozygote r variant cells were generally shown to have greater dendricity and express higher DCT than the WT cells, even at basal levels. The R151C+/ - heterozygote cells showed similar responses to WT cells, while the R160W+/- and D294H+/- variant cells were reduced in their responses to NDP-MSH, but still had an active cAMP response with forskolin treatment. These responses are consistent with the dominant negative effect of these alleles on the MC1R WT allele that has previously been demonstrated genetically and biochemically. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
163. Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
- Author
-
Mukherjee, Nabanita, Amato, Carol M., Skees, Jenette, Todd, Kaleb J., Lambert, Karoline A., Robinson, William A., Van Gulick, Robert, Weight, Ryan M., Dart, Chiara R., Tobin, Richard P., McCarter, Martin D., Fujita, Mayumi, Norris, David A., and Shellman, Yiqun G.
- Subjects
CANCER patients ,MELANOMA ,GENETIC mutation ,PROTEINS ,TREATMENT effectiveness - Abstract
There is an urgent need to develop treatments for patients with melanoma who are refractory to or ineligible for immune checkpoint blockade, including patients who lack BRAF-V600E/K mutations. This is often the case in patients diagnosed with rare melanoma subtypes such as mucosal and acral melanoma. Here, we analyzed data from the cutaneous melanoma The Cancer Genome Atlas Network (TCGA) transcriptomic and proteomic databases for differential expression of apoptosis molecules between melanomas with or without BRAF hotspot mutations. Our data indicated higher B-cell CLL/lymphoma 2 (BCL2) expression in melanoma without BRAF hotspot mutations, suggesting that BH3 mimetics, such as ABT-199 (venetoclax, a small molecule against BCL2), may be a potential therapeutic option for these patients. We explored the efficacy of combining two BH3 mimetics, ABT-199 and a myeloid cell leukemia sequence 1 (MCL1) inhibitor (S63845 or S64315/MIK665) in cutaneous, mucosal and acral melanomas, in vitro and in vivo. Our data indicate this combination induced cell death in a broad range of melanoma cell lines, including melanoma initiating cell populations, and was more potent in melanoma cells without BRAF-V600E/K mutations. Our knockdown/knockout experiments suggest that several pro-apoptotic BCL2 family members, BCL2-like 11 (apoptosis facilitator) (BIM), phorbol-12-myristate-13-acetate-induced protein 1 (NOXA) or BID, play a role in the combination-induced effects. Overall, our study supports the rationale for combining an MCL1 inhibitor with a BCL2 inhibitor as a therapeutic option in patients with advanced melanoma. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
164. Resistance to Neoadjuvant Treatment in Breast Cancer: Clinicopathological and Molecular Predictors.
- Author
-
Chica-Parrado, María Rosario, Godoy-Ortiz, Ana, Jiménez, Begoña, Ribelles, Nuria, Barragan, Isabel, and Alba, Emilio
- Subjects
CARCINOGENESIS ,BREAST tumors ,CANCER patients ,CANCER relapse ,CELL receptors ,COMBINED modality therapy ,DRUG resistance in cancer cells ,GENETIC mutation ,PRESERVATION of organs, tissues, etc. ,TRASTUZUMAB ,MICROMETASTASIS - Abstract
Neoadjuvant Chemotherapy (NAC) in Breast Cancer (BC) has proved useful for the reduction in tumor burden prior to surgery, allowing for a more extensive breast preservation and the eradication of subjacent micrometastases. However, the impact on prognosis is highly dependent on the establishment of Pathological Complete Response (pCR), in particular for Triple Negative (TN) and Hormonal Receptor negative/Human Epidermal growth factor Receptor 2 positive (HR−/HER2+) subtypes. Several pCR predictors, such as PAM50, Integrative Cluster (IntClust), mutations in PI3KCA, or the Trastuzumab Risk model (TRAR), are useful molecular tools for estimating response to treatment and are prognostic. Major evolution events during BC NAC that feature the Residual Disease (RD) are the loss of HR and HER2, which are prognostic of bad outcome, and stemness and immune depletion-related gene expression aberrations. This dynamic nature of the determinants of response to BC NAC, together with the extensive heterogeneity of BC, raises the need to discern the individual and subtype-specific determinants of resistance. Moreover, refining the current approaches for a comprehensive monitoring of tumor evolution during treatment, RD, and eventual recurrences is essential for identifying new actionable alterations and the integral best management of the disease. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
165. Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors.
- Author
-
Giussani, Marta, Triulzi, Tiziana, Sozzi, Gabriella, and Tagliabue, Elda
- Subjects
EXTRACELLULAR matrix ,TUMOR microenvironment ,CANCER invasiveness ,TUMOR markers ,PROGNOSIS ,BREAST cancer prognosis - Abstract
In recent years, it has become increasingly evident that cancer cells and the local microenvironment are crucial in the development and progression of tumors. One of the major components of the tumor microenvironment is the extracellular matrix (ECM), which comprises a complex mixture of components, including proteins, glycoproteins, proteoglycans, and polysaccharides. In addition to providing structural and biochemical support to tumor tissue, the ECM undergoes remodeling that alters the biochemical and mechanical properties of the tumor microenvironment and contributes to tumor progression and resistance to therapy. A novel concept has emerged, in which tumor-driven ECM remodeling affects the release of ECM components into peripheral blood, the levels of which are potential diagnostic or prognostic markers for tumors. This review discusses the most recent evidence on ECM remodeling-derived signals that are detectable in the bloodstream, as new early diagnostic and risk prediction tools for the most frequent solid cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
166. VE-Cadherin Disassembly and Cell Contractility in the Endothelium are Necessary for Barrier Disruption Induced by Tumor Cells.
- Author
-
Aragon-Sanabria, Virginia, Pohler, Steven E., Eswar, Vikram J., Bierowski, Matthew, Gomez, Esther W., and Dong, Cheng
- Abstract
During metastasis, breakdown of the endothelial barrier is critical for tumor cell extravasation through blood vessel walls and is mediated by a combination of tumor secreted soluble factors and receptor-ligand interactions. However, a complete mechanism governing tumor cell transendothelial migration remains unclear. Here, we investigate the roles of tumor-associated signals in regulating endothelial cell contractility and adherens junction disassembly leading to endothelial barrier breakdown. We show that Src mediates VE-cadherin disassembly in response to metastatic melanoma cells. Through the use of pharmacological inhibitors of cytoskeletal contractility we find that endothelial cell contractility is responsive to interactions with metastatic cancer cells and that reducing endothelial cell contractility abrogates migration of melanoma cells across endothelial monolayers. Furthermore, we find that a combination of tumor secreted soluble factors and receptor-ligand interactions mediate activation of Src within endothelial cells that is necessary for phosphorylation of VE-cadherin and for breakdown of the endothelial barrier. Together, these results provide insight into how tumor cell signals act in concert to modulate cytoskeletal contractility and adherens junctions disassembly during extravasation and may aid in identification of therapeutic targets to block metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
167. Front & Back Matter.
- Subjects
PSYCHOLOGY of the sick ,HEALTH care teams ,COMORBIDITY ,SOCIOECONOMIC factors - Abstract
The article presents the front and back cover of "Oncology: International Journal of Cancer Research and Treatment" Volume 87 June 2014 issue.
- Published
- 2014
- Full Text
- View/download PDF
168. Inhalt Band 8, 2013.
- Abstract
No abstract available [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
169. Preface.
- Author
-
Mantovani, Alberto
- Abstract
A preface to this issue of the journal is presented.
- Published
- 2010
- Full Text
- View/download PDF
170. Telomerase and cancer.
- Author
-
Shay, Jerry W.
- Abstract
Highlights research advances in the use of telomerase in cancer diagnostics. Anti-telomerase cancer therapeutic approaches; RNA and protein reverse transcriptase subunit content of the eukaryotic ribonucleoprotein (RNP), telomerase; RNP's maintenance of telomere length stability in cancer cells.
- Published
- 2001
- Full Text
- View/download PDF
171. An evolutionarily conserved germ cell-specific hnRNP is encoded by a retrotransposed gene.
- Author
-
Elliott, David J.
- Abstract
Identifies a novel member of the heterogeneous ribonucleoprotein (HNRNP) G gene family, a family of nuclear RNA-binding proteins. Implication of the existence of an additional testis-specific hnRNP G family member; Evidence for the importance of the proteins in normal germ cell development; Cloning and analysis of the HNRNP G-T gene.
- Published
- 2000
- Full Text
- View/download PDF
172. Human immunodeficiency virus-1 (HIV-1)-Tat protein promotes migration of acquired immunodeficiency syndrome-related lymphoma cells and enhances their adhesion to endothelial cells
- Author
-
Federico Bussolino, Giulia Taraboletti, Mauro Giacca, Luca Barra, Giampiero Piccinini, Renato G. S. Chirivi, Raffaella Giavazzi, Maria Rosa Bani, Chirivi, R. G., Taraboletti, G., Bani, M. R., Barra, L., Piccinini, G., Giacca, Mauro, Bussolino, F., and Giavazzi, R.
- Subjects
Cell type ,Immunology ,Integrin ,Intercellular Adhesion Molecule-1 ,Biology ,Biochemistry ,immune system diseases ,Cell Movement ,hemic and lymphatic diseases ,Cell Adhesion ,Tumor Cells, Cultured ,Humans ,Cell adhesion ,Lymphoma, AIDS-Related ,Cell adhesion molecule ,Cell migration ,Cell Biology ,Hematology ,Endothelial stem cell ,Cell culture ,Gene Products, tat ,Cancer research ,biology.protein ,HIV-1 ,tat Gene Products, Human Immunodeficiency Virus ,Endothelium, Vascular - Abstract
Human immunodeficiency virus-1 (HIV-1)-Tat, the transactivating gene product of HIV-1, has been shown to interact with different cell types, inducing gene expression, altering their growth and migratory behavior. In this study we examined whether Tat might affect functions of acquired immunodeficiency syndrome (AIDS)-related non-Hodgkin’s lymphoma (NHL), relevant to the in vivo dissemination. Our results show that Tat significantly augmented the motility of the two AIDS-related Burkitt’s lymphoma cell lines (AS283 and PA682PB) and AIDS-primary effusion lymphoma cell line (HBL-6-AIDS-PEL). Mutations in RGD or basic domain of Tat (KGE-MBP and LxI-MBP, respectively) sharply reduced migration compared with wild type, suggesting that both domains are required for migration. In contrast, a Tat protein mutation outside the active domains (NH2-TAT-GST) did not reduce lymphoma cell migration. The treatment of lymphoma cells with Tat did not influence their adhesion to matrix proteins or to human vascular endothelial cells, but endothelial cells treated with Tat became more adhesive to lymphoma cells. Flow cytometric analysis showed that treatment of endothelial cells with Tat induced the cell surface expression of the adhesion molecules vascular cell adhesion molecule-1 (VCAM-1) and E-selectin and increased the expression of intercellular adhesion molecule-1 (ICAM-1). Only antibodies against VCAM-1 on endothelial cells or against the VLA-4 integrin expressed on AS283 cells inhibited the increment of adhesion, indicating the relevance of this pathway in the adhesion of lymphoma cells to vascular endothelium. In our work, we show for the first time that Tat can enhance the migration of lymphoma cells and their adhesion to endothelial cells, two processes that may contribute to the malignant behavior of NHL in patients with AIDS.
173. Necesidades psicosociales de mujeres con cáncer durante su diagnóstico: estudio para diseñar un programa psicoeducativo
- Author
-
Martínez Arriaga, Reyna Jazmín, de Jesús Hernández Delgado, Yolanda, Bravo Andrade, Héctor Rubén, Zamora Ávalos, Daniela, López Ventura, Berenice, Muñoz Anacona, Yineth Alejandra, Macias Espinoza, Fabiola, and Meza Chavolla, Sergio Osvaldo
- Published
- 2024
- Full Text
- View/download PDF
174. An innovative cellular medicine approach via the utilization of novel nanotechnology-based biomechatronic platforms as a label-free biomarker for early melanoma diagnosis
- Author
-
Alqabandi, Jassim A., David, Rhiannon, Abdel-Motal, Ussama M., ElAbd, Rawan O., and Youcef-Toumi, Kamal
- Published
- 2024
- Full Text
- View/download PDF
175. Breastfeeding and Human Lactation
- Author
-
Karen Wambach, Becky Spencer, Karen Wambach, and Becky Spencer
- Subjects
- Infants--Nutrition, Breast milk, Breastfeeding, Lactation
- Abstract
Breastfeeding and Human Lactation, Seventh Edition is the ultimate reference for the latest clinical techniques and research findings that direct evidence-based clinical practice and research for lactation consultants and specialists. It contains everything a nurse, lactation consultant, midwife, women's health nurse practitioner, physician assistant, or Ob/Gyn needs to know about lactation care and science. Topics include placing breastfeeding in its historical context, workplace-related issues, anatomical and biological imperatives of lactation, the prenatal and perinatal periods and concerns during the postpartum period, the mother's health, sociocultural issues, and more vital information.
- Published
- 2026
176. Handbook of Research on Advancements in Cancer Therapeutics
- Author
-
Sumit Kumar, Moshahid Alam Rizvi, Saurabh Verma, Sumit Kumar, Moshahid Alam Rizvi, and Saurabh Verma
- Subjects
- Tumors--Treatment
- Abstract
The complexity of cancer demands an integrated approach from both a cancer biology standpoint and a pharmaceutical basis to understand the different anticancer modalities. Current research has been focused on conventional and newer anticancer modalities, recent discoveries in cancer research, and also the advancements in cancer treatment. There is a current need for more research on the advances in cancer therapeutics that bridge the gap between basic research (pharmaceutical drug development processes, regulatory issues, and translational experimentation) and clinical application. Recent promising discoveries such as immunotherapies, promising therapies undergoing clinical trials, synthetic lethality, carbon beam radiation, and other exciting targeted therapies are being studied to improve and advance the studies of modern cancer treatment. The Handbook of Research on Advancements in Cancer Therapeutics serves as a comprehensive guide in modern cancer treatment by combining and merging the knowledge from both cancer biology and the pharmacology of anticancer modalities. The chapters come from multi-disciplinary backgrounds, including scientists and clinicians from both academia and various industries, to discuss nascent personalized therapies and big data-driven cancer treatment. While highlighting topic areas that include cancer prevention, cancer therapeutics, and cancer treatments through the lenses of technology, medicine/drugs, and alternate therapies, this book is ideally intended for oncologists, radiation oncologists, surgical oncologists, and cancer biologists, along with practitioners, stakeholders, researchers, academicians, and students who are interested in understanding the most fundamental aspects of cancer and the available therapeutic opportunities.
- Published
- 2021
177. Advances in Medicine and Biology. Volume 166
- Author
-
Leon V. Berhardt and Leon V. Berhardt
- Abstract
In this compilation, the authors review the available evidence of the benefits of benfotiamine administration, paying particular attention to patients with type 2 diabetes mellitus and diabetic peripheral neuropathy, cardiac autonomic neuropathy and gastrointestinal neuropathy. An overview of cyclic AMP response element binding protein's structure and functions is provided, in addition to a review of its molecular mechanisms and role in disease processes, including neural diseases, diabetes and cancer. Based on bibliographic references and studies carried out by the authors, this work also assesses the problem of modular total hip prostheses, regarded as a closed loop biotribosystem. The best available evidence in the field of dental rehabilitation is discussed, with the goal of constructing a reliable base for the approach of new investigations. In closing, the authors present the synthesis methods and pharmacological properties of triazole-derived heterocyclic systems. Triazoles are an important class of heterocyclic compounds that are five-membered aromatic azole ring with three nitrogen and two carbon atoms.
- Published
- 2020
178. Intersektorale Versorgung : Best Practices – erfolgreiche Versorgungslösungen mit Zukunftspotenzial
- Author
-
Ursula Hahn, Clarissa Kurscheid, Ursula Hahn, and Clarissa Kurscheid
- Subjects
- Integrated delivery of health care--Germany, Medical care--Germany
- Abstract
Das deutsche Gesundheitswesen ist ein sehr komplexes und hoch reguliertes Gebilde, geprägt durch eine historisch bedingte Sektorentrennung, eine staatsmittelbare Selbstverwaltung mit immer neuen Regulationen und Gesetzesreformen in zunehmend kürzeren Rhythmen. Zugleich zeichnet sich der erste Gesundheitsmarkt durch eine deutliche Geschlossenheit gegenüber Innovationen aus. Es ist einerseits schwierig, Neuerungen und sektorenübergreifende Versorgungsansätze zu implementieren, andererseits schaffen es viele gute Ideen und erfolgreiche Projekte nicht in die Regelversorgung. Doch knappe finanzielle Ressourcen, die demographische Entwicklung, die wachsenden medizinisch-technischen und digitalen Möglichkeiten sowie die interfachliche und interdisziplinäre Arbeitsteilung fordern geradezu neue intersektorale Ansätze. Tatsächlich gibt es trotz der Hürden gute und funktionierende intersektorale Lösungen. In diesem Herausgeberwerk werden knapp dreißig Best-Practice-Beispiele vorgestellt: Akteure ganz unterschiedlicher Provenienz berichten über ihre Lösungen, die von Kooperation verschiedener selbständiger Akteure bis Integration aller Versorgungsebenen unter einem Dach reichen. Dabei orientieren sie sich an Gütekriterien, wie z.B. Qualität der Patientenversorgung, Effizienzpotenziale, Skalierbarkeit oder Anforderungen an einen notwendigen Strukturwandel. Die Erfahrungen dieser Best-Practice-Beispiele können und sollen für die Weiterentwicklung einer modernen und patientenorientierten intersektoralen Versorgung nutzbar gemacht werden.
- Published
- 2020
179. Advances in Medicine and Biology. Volume 143
- Author
-
Leon V. Berhardt and Leon V. Berhardt
- Abstract
The opening chapter of Advances in Medicine and Biology. Volume 143 discusses the main indications of prophylactic oophorectomy, as well as its risks, benefits and impacts on women's quality of life. Additionally, the authors examine PEGylation, a chemical reaction that allows for the conjugation of a polyethylene-glycol group to another compound. Since the commercial release of adagen, the first approved PEGylated drug, PEGylation has proven to be a successful strategy for the generation of efficient drugs. Following this, this compilation analyzes the morphological and functional disorders that may be induced by oxaliplatin. The authors present the possible side effects of this drug upon several organs, as well as the mechanisms that are activated by the nominated drug. The authors also summarize the processes that might be occurring in Werner syndrome cells during DNA replication that then lead to the genomic instability and replication stress and, ultimately, a p38a-induced premature senescence. The results of the authors'studies combining the granulocyte colony-stimulating factor and enteral sorption therapy are presented in the closing chapter to ameliorate common side effects of such potent and toxic anti-cancer alkylating agents, such as melphalan.
- Published
- 2019
180. Revival: Principles of Cell Adhesion (1995)
- Author
-
Peter D. Richardson, Manfred Steiner, Peter D. Richardson, and Manfred Steiner
- Subjects
- Cell adhesion molecules, Cell adhesion
- Abstract
Intended for cell biologists, biophysicists, biochemists, molecular biologists, physiologists, researchers in hemostatsis and thrombosis and pathologists, this book provides an insight into cell adhesion from three interdisciplinary perspectives: fundamental facts of adhesion; molecular biochemistry of adhesion and physiological aspects. It summarizes the basic aspects of surfaces in general and describes the theoretical and experimental tools necessary to investigate cell adhesion, including the basic biochemistry and molecular biology of adhesion. The book offers concise treatment of individual topics, features current material, and provides key references as a guide to further study.
- Published
- 2017
181. Tumor Matrix Biology (1995)
- Author
-
Roza Adany and Roza Adany
- Subjects
- Tumors--Blood-vessels, Tumors--Growth, Metastasis
- Abstract
This book would like to present the latest findings on different aspects of tumor matrix formation in connection with the tumor progression and metastasis and on alterations in the cellular components of tumor stroma during tumor demarcation and invasion.
- Published
- 2017
182. Horizons in Cancer Research
- Author
-
Watanabe, Hiroto S. and Watanabe, Hiroto S.
- Subjects
- Cancer--Research, Cancer--Treatment
- Abstract
This book presents original results on the leading edge of cancer research. Chapter One provides a brief overview of the recent updates in the role of the laboratory in establishing the diagnosis, methods of disease monitoring and mechanisms that contribute to tyrosine kinase inhibitor (TKI) resistance for patients with chronic myeloid leukemia. Chapter Two reviews self-esteem and academic difficulties in preadolescents and adolescents health from pediatric leukemia. Chapter Three analyzes the role of lactoferrin expression in the initiation and progression of most common hormone-dependent cancers. Chapter Four studies the ETS transcription factor FLI-1 as an important player in human cancer. Chapter Five highlights the latest advances in DNA methylation signature- based liquid biopsy. Chapter Six presents data concerning the pharmacological activity of water-soluble complex of quercetin with polyvinylpyrrolidone on the process of bleomycin-induced lung fibrosis in mice. Chapter Seven investigates prospects of enhancing anti-cancer activities of quercetin in the treatment of glioblastoma. Chapter Eight discusses the correction of tumor-associated thrombocytopenia by quercetin. Chapter Nine examines robotic surgery for prostate cancer.
- Published
- 2017
183. Einweiser- und Patientenbeziehungsmanagement im Krankenhaus : Die Option der direkten Patientenakquisition und -bindung
- Author
-
Katrin Burghardt and Katrin Burghardt
- Subjects
- Medical economics, Hospital-physician relations, Hospitals--Administration, Medical referral, Physician and patient
- Abstract
Katrin Burghardt stellt den „state of the art“ des Einweisermanagements in deutschen Akutkliniken dar und zeigt, in welcher Art und Weise und in welchem Umfang Kliniken gezielte Maßnahmen eines Einweisermanagements bereits einsetzen. Sie untersucht, welche möglichen zukünftigen Einsatzfelder und Perspektiven Krankenhäuser im Rahmen des Managements ihrer Einweiserbeziehungen sehen. Die Autorin zeigt auf, dass der Patient aufgrund der zunehmenden Patientensouveränität als Kunde stark an Bedeutung gewinnen wird und die Kliniken sich künftig auf die Rolle eines aktiven Patienten einstellen müssen.
- Published
- 2016
184. Biomedical Photonics Handbook, 3 Volume Set
- Author
-
Tuan Vo-Dinh and Tuan Vo-Dinh
- Subjects
- Diagnostic Imaging--instrumentation, Diagnostic Imaging--methods, Biosensing Techniques--instrumentation, Biosensing Techniques--methods, Photons--diagnostic use
- Abstract
This handbook presents the most recent technological advances and applications in the areas of biomedical photonics. This second edition contains introductory material and covers the state-of-the-art methods and instrumentation for biomedical photonic technologies. It integrates interdisciplinary research and development critically needed for scientists, engineers, manufacturers, teachers, students, and clinical providers to learn about the most recent advances and predicted trends in instrumentation and methods as well as clinical applications in important areas of biomedical photonics. Extensive references are provided to enhance further study.
- Published
- 2015
185. Biomedical Photonics Handbook : Biomedical Diagnostics
- Author
-
Tuan Vo-Dinh and Tuan Vo-Dinh
- Subjects
- Optoelectronic devices--Handbooks, manuals, etc, Photons, Biosensors--Handbooks, manuals, etc, Diagnostic imaging--Handbooks, manuals, etc, Imaging systems in medicine--Handbooks, manuals, etc
- Abstract
Shaped by Quantum Theory, Technology, and the Genomics RevolutionThe integration of photonics, electronics, biomaterials, and nanotechnology holds great promise for the future of medicine. This topic has recently experienced an explosive growth due to the noninvasive or minimally invasive nature and the cost-effectiveness of photonic modalities in
- Published
- 2014
186. Molecular Imaging of Small Animals : Instrumentation and Applications
- Author
-
Habib Zaidi and Habib Zaidi
- Subjects
- Laboratory animals, Biology--Research--Technique, Veterinary diagnostic imaging, Imaging systems in biology, Medicine--Research--Technique
- Abstract
This book examines the fundamental concepts of multimodality small-animal molecular imaging technologies and their numerous applications in biomedical research. Driven primarily by the widespread availability of various small-animal models of human diseases replicating accurately biological and biochemical processes in vivo, this is a relatively new yet rapidly expanding field that has excellent potential to become a powerful tool in biomedical research and drug development.In addition to being a powerful clinical tool, a number of imaging modalities including but not limited to CT, MRI, SPECT and PET are also used in small laboratory animal research to visualize and track certain molecular processes associated with diseases such as cancer, heart disease and neurological disorders in living small animal models of disease. In vivo small-animal imaging is playing a pivotal role in the scientific research paradigm enabling to understand human molecular biology andpathophysiology using, for instance, genetically engineered mice with spontaneous diseases that closely mimic human diseases.
- Published
- 2014
187. DNA Tumor Viruses : Oncogenic Mechanisms
- Author
-
Giuseppe Barbanti-Brodano, Mauro Bendinelli, Herman Friedman, Giuseppe Barbanti-Brodano, Mauro Bendinelli, and Herman Friedman
- Subjects
- Oncology, Medical microbiology, Botany, Anatomy, Comparative, Microbial ecology
- Abstract
DNA tumor viruses have long been useful experimental models of carcinogenesis and have elucidated several important mechanisms of cell transformation. Re search in recent years has shown that human tumors have a multifactorial nature and that some DNA tumor viruses may playa key role in their etiology. The aim of this book is to assess our knowledge of DNA tumor viruses by reviewing animal models, mechanisms of transformation, association with human tumors, and possi bilities of prevention and control by vaccination. Animal models of tumor virology have contributed significantly to our under standing of the epidemiology and pathogenesis of virus-induced tumors. Bovine papillomaviruses induce papillomas in the intestine of cattle. The papillomas undergo a transition to carcinomas in cows feeding on bracken fern, which pro duces a toxin with radiomimetic and immunosuppressive functions. This example of cooperation between a virus and chemical carcinogens parallels the cooperative role of human papillomaviruses (HPVs) and herpes simplex virus type 2 (HSV-2) with environmental carcinogens in the pathogenesis of cervical cancer. Likewise, hepatocarcinomas appearing in woodchucks chronically infected by woodchuck hepatitis virus (WIN) provide strong support for the relationship between hepatitis B virus (HBV) infection and human hepatocellular carcinoma. Also, the fact that WIN DNA integrates closely to cellular oncogenes suggests a possible molecular mechanism for the tumorigenesis induced by HBV.
- Published
- 2013
188. The Retroviridae
- Author
-
Jay A. Levy and Jay A. Levy
- Subjects
- Medical microbiology, Botany, Anatomy, Comparative, Microbial ecology
- Abstract
The books in this acclaimed series are the most detailed, up-to-date accounts of the field available. Volume 3 explores the oncogenic potential shared by retroviruses of different species, the widespread presence of retrovirues in nature, and the role of retroviruses in normal development and pathogenesis.
- Published
- 2013
189. Krankheit im Zentrum : Gestaltung von krankheitsorientierten Spitalstrukturen aus kybernetisch -konstruktivistischer Sicht
- Author
-
Astrid Erbsen and Astrid Erbsen
- Subjects
- Hospital buildings--Specifications, Hospital buildings--Planning, Disease management, University hospitals
- Abstract
Diese Doktorarbeit an der Universität St. Gallen (HSG) entwickelt ein Strukturmodell von krankheitsorientierten Zentren an Universitätsklinika. Das Modell basiert auf einer kybernetisch-konstruktivistischen Sichtweise sowie den Erkenntnissen aus umfangreichen Einzelfallstudien in Eusoma-akkreditierten universitären Brustzentren. Es zeigt, welche Strukturen ein idealtypisches Zentrum zum Zweck der optimalen Patientenversorgung aufweisen sollte sowie welches die wesentlichen Herausforderungen im Veränderungsprozess sind. (Damit liefert das Buch Praktikern im Gesundheitswesen wertvolle Hinweise zur Konzeption von universitären Klinikstrukturen, die das Entstehen von krankheitsorientierten Verhaltensweisen wie Interdisziplinarität unterstützen.)
- Published
- 2012
190. Plant Cytogenetics : Genome Structure and Chromosome Function
- Author
-
Hank Bass, James A. Birchler, Hank Bass, and James A. Birchler
- Subjects
- Plant cytogenetics, Plant chromosomes
- Abstract
This reference book provides information on plant cytogenetics for students, instructors, and researchers. Topics covered by international experts include classical cytogenetics of plant genomes; plant chromosome structure; functional, molecular cytology; and genome dynamics. In addition, chapters are included on several methods in plant cytogenetics, informatics, and even laboratory exercises for aspiring or practiced instructors. The book provides a unique combination of historical and modern subject matter, revealing the central role of plant cytogenetics in plant genetics and genomics as currently practiced. This breadth of coverage, together with the inclusion of methods and instruction, is intended to convey a deep and useful appreciation for plant cytogenetics. We hope it will inform and inspire students, researchers, and teachers to continue to employ plant cytogenetics to address fundamental questions about the cytology of plant chromosomes and genomes for years to come.Hank W. Bass is a Professor in the Department of Biological Science at Florida State University.James A. Birchler is a Professor in the Division of Biological Sciences at the University of Missouri.
- Published
- 2012
191. Telomerases : Chemistry, Biology, and Clinical Applications
- Author
-
Neal F. Lue, Chantal Autexier, Neal F. Lue, and Chantal Autexier
- Subjects
- Telomerase--Genetics, Telomerase--Metabolism, Telomerase--Physiology, Geriatrics, Telomerase
- Abstract
This book is a comprehensive and up-to-date review and evaluation of the contemporary status of telomerase research. Chapters in this volume cover the basic structure, mechanisms, and diversity of the essential and regulatory subunits of telomerase. Other topics include telomerase biogenesis, transcriptional and post-translational regulation, off-telomere functions of telomerase and the role of telomerase in cellular senescence, aging and cancer. Its relationship to retrotransposons, a class of mobile genetic elements that shares similarities with telomerase and serves as telomeres in selected organisms, are also reviewed.
- Published
- 2012
192. EJB Reviews
- Author
-
P. Christen, E. Hofmann, P. Christen, and E. Hofmann
- Subjects
- Biochemistry, Cytology, Internal medicine
- Abstract
In the mid-1980s the European Journal of Biochemistry set out to publish review articles. The enterprise proved successful, resulting in high-level reviews written by well-known scientists appearing in the Journal. The reviews represent emerging and rapidly growing fields of research in fundamental as well as applied areas of biochemistry, such as medicine, biotechnology, agriculture and nutrition. Novel methodological and technological approaches which stimulate biochemical research are also included. The authors of the reviews are explicitly asked to be critical, selective, evaluative and interdisciplinary oriented. The reviews should encourage young scientists to think independently and creatively, and inform active investigators about the state of the art in a given field.
- Published
- 2012
193. Methods of Cancer Diagnosis, Therapy and Prognosis : Breast Carcinoma
- Author
-
M. A. Hayat and M. A. Hayat
- Subjects
- Breast--Cancer--Treatment, Breast--Cancer--Diagnosis
- Abstract
The enormity of the global healthcare costs vical. One-fifth of all cancers worldwide as a result of cancer infliction cannot be are caused by a chronic infection, for overemphasized. There are more than 100 example, human papilloma virus (HPV) types of cancers; any part of the body can causes cervical cancer and hepatitis B be affected. More than 11 million people virus (HBV) causes liver cancer. Tobacco are diagnosed with cancer every year, and use is the most common preventable cause it is estimated that there will be 16 mil- of cancer in the world. Approximately, lion new cases per year by the year 2020. 168,000 cancer deaths are expected to be In 2005, 7. 6 million people died of can- caused by tobacco use. Approximately, cer, that is, 13% of the 58 million deaths 40% of cancer could be prevented, mainly worldwide. It is estimated that 9 million by not using tobacco, having a healthy people will die from cancer worldwide in diet, being physically active, preventing 2015 and 11. 4 million will die in 2030. infections that may cause cancer, reduc- More than 70% of all cancer deaths occur ing exposure to sunlight, and avoidance of in low and middle income countries. excessive alcohol consumption and stress Five major cancer causing overall mor- (anger). A third of cancers could be cured talities per year worldwide are (WHO): if detected early and treated adequately. It is well established that scientific 1. Lung: 1.
- Published
- 2008
194. Red Cell Development
- Author
-
Bieker, James J. and Bieker, James J.
- Subjects
- Erythrocytes
- Abstract
This compendium provides a concise and up-to-date assessment of critical recent issues related to erythroid biology. Developmental, epigenetic, methodological, biochemical, and clinical aspects are integrated to provide a powerful overview of their interrelationships and importance to the generation of the red cell. The excitement generated by these novel observations and the anticipation of future directions in studies of the red cell is a highlight of this volume. The first comprehensive volume covering the breadth of the topic The latest advancements that lead to novel directions in the study of red cells An informative discussion of red cells as they relate to the essential oxygen-carrying component of the body
- Published
- 2008
195. Prostate Cancer : Biology, Genetics, and the New Therapeutics
- Author
-
Leland W. K. Chung, William B. Isaacs, Jonathan W. Simons, Leland W. K. Chung, William B. Isaacs, and Jonathan W. Simons
- Subjects
- Prostate--Cancer--Genetic aspects, Prostate--Cancer, Prostate--Cancer--Treatment
- Abstract
Prostate Cancer: Biology, Genetics, and the New Therapeutics, Second Edition, reviews new, valuable approaches to the treatment of prostate cancer in men. The latest edition contains new material on molecular imaging, new treatments for prostate cancer, molecular targets, cell signaling pathways, bioinformatics, and pathogenomics. The book details the latest innovations and advances in prostate cancer and may be used as a rapid reference text for readers. The volume profiles the latest advances in cancer research and treatment and includes profound studies in prostate stem cells, cancer-host interactions, hedgehog signaling in development and cancer, cholesterol and cell signaling, gene therapy for advanced prostate cancer, and noninvasive strategies such as molecular imaging to visualize gene expression. This new edition also investigates expression profiling and somatic alterations in prostate cancer progression and linkage studies of prostate cancer families to identify susceptibility genes. The issues of racial differences in prostate cancer mortality, radiotherapy for the treatment of locally advanced prostate cancer, recombinant antibody candidates for treatment, taxane-based chemotherapy, lethal phenotypes, and novel and efficient translation clinical trials are also presented in great depth. Prostate Cancer: Biology, Genetics, and the New Therapeutics, Second Edition, provides readers with a general reference for prostate cancer from prevention to therapy and will be of value to clinicians, scientists, and administrators who strive to solve the cancer problem.
- Published
- 2007
196. Peptide Characterization and Application Protocols
- Author
-
Fields, Gregg B. and Fields, Gregg B.
- Subjects
- Peptides--Analysis
- Abstract
Peptide Characterization and Application Protocols is dedicated entirely to the characterization of peptides and their applications for the study of biochemical systems and the contributing authors are all leaders in the field of peptide research. Part I, Characterization, presents the most recent advances in select analytical techniques, including high-performance liquid chromatography (HPLC) for purification and evaluation of peptides and mass spectrometry (MS) for the analysis of standard and modified peptides. Innovative methods of synthesis and characterization of membrane peptides are also presented. Part II, Application, presents a variety of specific applications for synthetic peptides. The collected protocols demonstrate the systematic manner in which peptides can be constructed, analyzed, and applied to attack contemporary problems in biochemistry, and this book will be an indispensable aid in the pursuit of new directions in peptide research.
- Published
- 2007
197. Progress in Nucleic Acid Research and Molecular Biology
- Author
-
Kivie Moldave and Kivie Moldave
- Subjects
- Nucleic acids, Molecular biology
- Abstract
Nucleic acids are the fundamental building blocks of DNA and RNA and are found in virtually every living cell. Molecular biology is a branch of science that studies the physicochemical properties of molecules in a cell, including nucleic acids, proteins, and enzymes. Increased understanding of nucleic acids and their role in molecular biology will further many of the biological sciences including genetics, biochemistry, and cell biology. Progress in Nucleic Acid Research and Molecular Biology is intended to bring to light the most recent advances in these overlapping disciplines with a timely compilation of reviews comprising each volume.
- Published
- 2006
198. Advances in Virus Research
- Author
-
Maramorosch, Karl, Shatkin, Aaron J., Maramorosch, Karl, and Shatkin, Aaron J.
- Subjects
- Virology--Research
- Abstract
Published since 1953, Advances in Virus Research covers a diverse range of in-depth reviews providing a valuable overview of the current field of virology.In 2004, the Institute for Scientific Information released figures showing that the series has an Impact Factor of 2.576, with a half-life of 7.1 years, placing it 11th in the highly competitive category of Virology.
- Published
- 2006
199. Ischemic Heart Disease : A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Author
-
Parker, Philip M., Parker, James N., Parker, Philip M., and Parker, James N.
- Subjects
- Coronary heart disease--Computer network resources, Coronary heart disease--Bibliography, Coronary heart disease--Electronic information sources, Coronary heart disease--Information sources, Coronary heart disease--Dictionaries
- Abstract
Title from e-book title screen (viewed on March 19, 2005)
- Published
- 2004
200. Traumatic Brain Injury : A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
- Author
-
Parker, James N., Parker, Philip M., Parker, James N., and Parker, Philip M.
- Subjects
- Brain--Wounds and injuries--Computer network resources, Brain--Wounds and injuries--Bibliography, Brain--Wounds and injuries--Dictionaries, Brain--Wounds and injuries--Popular works, Brain--Wounds and injuries--Research
- Abstract
Title from ebook title screen (viewed August 31, 2004).
- Published
- 2004
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.